KLF15 Antikörper (AA 1-260)
-
- Target Alle KLF15 Antikörper anzeigen
- KLF15 (Kruppel-Like Factor 15 (KLF15))
-
Bindungsspezifität
- AA 1-260
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser KLF15 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Recombinant Human Krueppel-like factor 15 protein (1-260AA)
- Isotyp
- IgG
- Top Product
- Discover our top product KLF15 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- KLF15 (Kruppel-Like Factor 15 (KLF15))
- Andere Bezeichnung
- KLF15 (KLF15 Produkte)
- Hintergrund
-
Background: Transcriptional regulator that binds to the GA element of the CLCNKA promoter. Binds to the KCNIP2 promoter and regulates KCNIP2 circadian expression in the heart (By similarity). Is a repressor of CTGF expression, involved in the control of cardiac fibrosis. It is also involved in the control of cardiac hypertrophy acting through the inhibition of MEF2A and GATA4 (By similarity). Involved in podocyte differentiation (By similarity). Inhibits MYOCD activity. Is a negative regulator of TP53 acetylation. Inhibits NF-kappa-B activation through repression of EP300-dependent RELA acetylation.
Aliases: Kidney enriched Kruppel like factor antibody, Kidney-enriched krueppel-like factor antibody, KKLF antibody, KKLF protein antibody, KLF 15 antibody, KLF15 antibody, KLF15_HUMAN antibody, Krueppel-like factor 15 antibody, Kruppel like factor 15 antibody
- UniProt
- Q9UIH9
-